Abstract
Musculoskeletal degenerative diseases (MSDDs) are pathological conditions that affect muscle, bone, cartilage, joint and connective tissue, leading to physical and functional impairments in patients, mainly consist of osteoarthritis (OA), intervertebral disc degeneration (IDD), rheumatoid arthritis (RA) and ankylosing spondylitis (AS). Long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs) are novel regulators of gene expression that play an important role in biological regulation, involving in chondrocyte proliferation and apoptosis, extracellular matrix degradation and peripheral blood mononuclear cell inflammation. Research on MSDD pathogenesis, especially on RA and AS, is still in its infancy and major knowledge gaps remain to be filled. The effects of lncRNA/circRNA-miRNA-mRNA axis on MSDD progression help us to fully understand their contribution to the dynamic cellular processes, provide the potential OA, IDD, RA and AS therapeutic strategies. Further studies are needed to explore the mutual regulatory mechanisms between lncRNA/circRNA regulation and effective therapeutic interventions in the pathology of MSDD.
Introduction
Musculoskeletal degenerative diseases (MSDDs) are pathological conditions that affect muscle, bone, cartilage, joint and connective tissue, leading to physical and functional impairment in patients (Chen Y. et al., 2017; Huo et al., 2018). With the acceleration of the global aging process, the prevalence of MSDD is increasing. This is a huge challenge for patients and healthcare workers, and adds to the global healthcare burden (Li and Chen, 2019). The main MSDD consists of osteoarthritis (OA), intervertebral disc degeneration (IDD), rheumatoid arthritis (RA), and ankylosing spondylitis (AS) (Vinatier et al., 2016; Huo et al., 2018; Loef et al., 2018). OA is a chronic age-related MSDD, featuring for subchondral bone thickening, articular cartilage degradation, and osteophyte formation (Loeser et al., 2012; Hunter and Bierma-Zeinstra, 2019). IDD is also age-related and is caused by progressive degeneration of the disk (Yang S. et al., 2020), causing loss of disk height, reduced hydration and decreased potential to absorb load (Samartzis et al., 2011; Cooper et al., 2016). RA is an autoimmune disease characterized by aggressive arthritis that can lead to joint deformities and loss of function (Smolen et al., 2016). AS, a rare but clear cause of chronic back pain, is an inflammatory disease involving the spine, sacroiliac joints and other joints (Taurog et al., 2016). OA and IDD became mainly responsible for MSDD. Their common character is the broken dynamic equilibrium between catabolism and anabolism in the extracellular matrix (ECM). On the one hand, chondrocytes is only resident cells in the articular system, the ECM degeneration in OA is leaded by chondrocytes’ catabolic and abnormal differentiation (Zhou Z.B. et al., 2019). Cartilage cellularity is reduced in OA because of chondrocyte death. On the other hand, ECM breakdown and abnormal matrix synthesis in IDD is responsible by nucleus pulposus (NP) cells, which are predominant cells in the NP tissue (Fontana et al., 2015). Excessive apoptosis of NP cells could accelerate IDD progression (Zhao et al., 2006). Meanwhile, endplate cartilage degeneration is another risk factor of IDD (Iwakura et al., 2013) due to its irreplaceable nutrition supplement of intervertebral disk (Yuan et al., 2015). Although multiple factors are involved in the pathogenesis of MSDD (Li and Chen, 2019), the development of molecular mechanism of MSDD is still poor. Thus, it is urgent to discover new biomarkers to optimize MSDD early diagnosis and treatment.
With the development of sequencing technology, recent advances have shown that about 98% of the human genome is composed of non-coding RNAs (ncRNAs). In the past, ncRNAs were thought to act as ‘evolutionary junk.’ However, an increasing amount of evidence reported that ncRNAs play an important role in biological regulation (Beermann et al., 2016; Vieira et al., 2018). The main types of ncRNAs include long non-coding RNA (lncRNA), circular RNA (circRNA) and microRNA (miRNA) (Beermann et al., 2016). Recently, extensive evidence suggested that ncRNAs play a vital role in the development of MSDD (Chen W.K. et al., 2017; Yu and Sun, 2018; Wang J. et al., 2019). Moreover, circRNA and lncRNA can interact with miRNA to further regulate downstream target mRNA in the MSDD and play regulatory roles in numerous biological functions, such as proliferation, apoptosis and inflammation. In this review, we focused on the role of lncRNA/circRNA-miRNA-mRNA axis in the development of MSDD and further explored related molecular mechanism of MSDD.
Interactions Between lncRNA/circRNA and miRNA
Interactions Between lncRNA and miRNA
MicroRNAs are encoded by endogenous genes, are approximately 20 nucleotides in length and are non-coding single-stranded RNA molecules (Beermann et al., 2016). Since they were first described in Caenorhabditis elegans, the number of miRNAs that have been found in mammals increased (Lee et al., 1993). miRNA is evolutionarily conserved and regulates gene expression at the post-transcriptional level by interfering with mRNA translation and degradation (Zhang et al., 2020b). With the iteration of gene chip and sequencing technology, numerous miRNAs have been found to play important roles in MSDD and can be used as biomarkers for clinical diagnosis and treatment (Satoshi Yamashita, 2012; Seeliger et al., 2016; Moran-Moguel et al., 2018). lncRNAs refers to non-protein-coding transcripts with the lengths of more than 200 nucleotides (Beermann et al., 2016). According to the position of the protein-encoding genes in the genome, lncRNAs are divided into five types, namely, intronic, intergenic, bidirectional, sense and antisense (Wang J. et al., 2019). More and more evidence argues that lncRNAs can act as an enhancer or suppressor to regulate the immune response at the epigenetic level, function as scaffold molecules through interactions with RNA-binding proteins in chromatin remodeling complexes (Mathy and Chen, 2017), and then, are involved in many cellular and biological processes in MSDD, such as proliferation, apoptosis, differentiation, inflammation and ECM degradation (Jiang et al., 2017; Li Z. et al., 2018; Abbasifard et al., 2020). Thus, it is important to develop lncRNA as a biomarker and therapeutic target for MSDD.
In recent years, extensive evidence has shown that lncRNAs can interact with miRNAs through several post-transcriptional mechanisms, and the four mechanisms of interaction are as follows. (1) lncRNAs act as miRNA sponges. The lncRNA that can prevent miRNA from acting on mRNA is called competing endogenous RNAs (ceRNAs). These lncRNAs have similar miRNA targets, and they can act as sponges of miRNA, thereby reducing the expression of miRNA and enhancing the translation of target mRNA. lncRNA AK048451 was first considered as an endogenous sponge of miR-489 that can combine with and inhibit the expression of miR-489 (Huang, 2018). (2) Several lncRNAs could directly compete with miRNAs to bind with mRNAs, thereby removing the regulatory roles of miRNAs on mRNAs. For example, lncRNA BACE1AS competes with miR-485-5p to combine with BACE1 mRNA. Thus, the degradation of BACE1 induced by miR-485-5p was inhibited (Faghihi et al., 2010). (3) miRNAs aim at lncRNAs to decrease the stability of lncRNAs and affect the abundance of lncRNAs. It has been verified that lncRNA-p21 was modulated by miRNA let-7b. Upregulation of let-7b promoted the degradation of RNA, leading to the instability of lncRNA-p21 (Deng et al., 2016). (4) Several lncRNAs could generate miRNAs. For instance, lncRNA H19 can generate miR-675 (Deng et al., 2016). To achieve a better understanding of the molecular mechanisms in MSDD progression, in-depth studies about the effects of lncRNAs and their potential downstream miRNA regulators have been performed in recent years.
Interactions Between circRNA and miRNA
As endogenous RNAs, circRNAs are characterize by covalent loop structures without 5′–3′ polarity nor a polya- denylated tail (Zhou et al., 2018). Different from linear RNA, circRNAs are inherently conserved due to their closed covalent structure and resistance to exonuclides; they are considered to be stable in exosomes (Haque and Harries, 2017). circRNAs are classified into four types according to their origin, namely, exonic circRNAs, exon-intron circRNAs, intronic circRNAs and intergenic circRNAs (Deng et al., 2016). A growing number of studies indicate that circRNAs exist miRNA complementary binding sites to interact with miRNAs, thereby playing regulatory roles in diseases and effecting in many biological processes, such as inflammation, apoptosis and ECM degradation, by participating in the modulation of transcriptional and post-transcriptional levels (Rong et al., 2017; Verduci et al., 2019). The mechanisms included circRNAs acting as miRNAs sponges and miRNAs regulating circRNAs (Kulcheski et al., 2016). For instance, the circAnks1a could regulate VEGFB (vascular endothelial growth factor-B) expression to suppress the excitability of spinal cord by sponging miR-324-3p in neuropathic pain (Zhang S.B. et al., 2019). Pan et al. (2019) elucidated that the miR-1224 could mediate circRNA-Filip1l expression through regulating Ubr5 in the spinal cord of chronic inflammatory pain mice. Although circRNAs are generally considered as ncRNAs because of non-linear structure, several circRNAs, such as CircFBXW7 (Ye et al., 2019) and Circ-EGFR (Liu et al., 2021), are proved to have translation functions due to its translatable open reading frame containing a start codon. The cap-independent translation pathway is thought to be the main mechanism of circRNA translation to encode protein (He et al., 2021). Combined with the above explanation, currently known that circRNAs can interact with proteins or act as miRNA sponges and regulate the expression of upstream gene to participate in the process of diseases development. In recent years, circRNAs have become a research hotspot in MSDD and showed great potential as biomarkers and therapeutic targets (Li H.Z. et al., 2018; Lei B. et al., 2019; Wu et al., 2019).
Interactions Among lncRNA, miRNA, and mRNA in Degenerative Musculoskeletal Diseases
Osteoarthritis
In the past decade, quite number of studies have shown that the interaction between lnRNAs and miRNAs is involved in the multiple biological processes of OA, such as inflammation, proliferation, apoptosis, autophagy, cell viability and ECM degradation (Table 1). The major interaction mechanism between lncRNA and miRNA in OA was that lncRNAs as ceRNAs acts as miRNAs sponges. Wang Q. et al. (2017) reported that the expressions of lncRNA OPN and NEAT1 significantly increased, whereas that of miR-181c decreased. According to luciferase assays, miR-181c could combine with NEAT1 and 3′UTR of OPN in synoviocytes, leading to NEAT1 competing with OPN for binding with miR-181c and further enhancing the level of OPN. Chen Y. et al. (2020) showed that lncRNA HOTAIR (HOX transcript antisense intergenic RNA) and mRNA PTEN (phosphatase and tensin homolog) was significantly increased in the OA mice, whereas miR-20b decreased. HOTAIR was involved in the process of apoptosis and ECM degradation by sponging miR-20b and regulating the downstream target PTEN. Lu and Zhou (2020) revealed that lncRNA00662 was downregulated in the cartilage of OA rats. The expression of miR-15b-5p was negative with lncRNA00662, whereas the expression of GPR120 was positively correlated with lncRNA00662. lncRNA00662 regulated GPR120 in apoptosis by serving as a sponge for miR-15b-5p. Sun P. et al. (2020) also studied the effect of XIST on OA patients and showed that XIST upregulated SGTB and inhibited the depression on SGTB induced by miR-142-5p through sponging miR-142-5p. Another study reported that the level of lnc00623 and HRAS was downregulated, whereas miR-101 was increased in OA tissues compared with normal tissues (Lü et al., 2020). Based on luciferase reporter, miR-101 could combine with lnc00623 and HRAS. lnc00623 sponges miR-101 through competing with HRAS, thereby preventing the miR-101-induced depression on HRAS. Some other lncRNAs act as miRNAs sponges in OA and more detailed information is presented in Table 1.
TABLE 1
| Species | Diseases | Region | lncRNA | Change | miRNA | Expression | Target gene | Change | Functions | References | |
| (1) | Human | OA | Cartilage | H19 | Up | miR-675 | Up | COL2A1 | Up | Inflammation | Steck et al., 2012 |
| (2) | Human, mice | OA | Cartilage, chondrocyte | GAS5 | Up | miR-21 | Down | MMPs, ADAMTS-4 | Up | Cell apoptosis and autophagy | Song et al., 2014 |
| (3) | Human | OA | Cartilage, chondrocyte | lncRNA-MSR | Up | miRNA-152 | Down | TMSB4 | Up | ECM degradation | Liu et al., 2016a |
| (4) | Human | OA | Cartilage, chondrocyte | UFC1 | Down | miR-34a | Up | – | – | Cell proliferation and apoptosis | Zhang et al., 2016 |
| (5) | Human | OA | Chondrocyte, C28/I2 cells | HOTAIR | Up | miR-17-3p | Down | ETV1 | Up | Cell apoptosis and inflammation | Chen H. et al., 2017 |
| (6) | Human | OA | Cartilage, chondrocyte | lncRNA PVT1 | Up | miR-488-3p | Down | – | – | Cell apoptosis | Li Y. et al., 2017 |
| (7) | Human | OA | Cartilage, chondrocyte | lncRNA CIR | Up | miR-27 | Down | MMP13 | Up | ECM degradation | Li Y.F. et al., 2017 |
| (8) | Human | OA | Cartilage, chondrocyte | lncRNA -UCA1 | Up | miR-204-5p | Down | MMP13 | Up | Cell proliferation | Wang G. et al., 2017 |
| (9) | Human | OA | Synovium tissues, synoviocytes | NEAT1 | Up | miR-181c | Down | OPN | Up | Cell proliferation | Wang Q. et al., 2017 |
| (10) | Rats | OA | Cartilage, chondrocyte | lncRNA MEG3 | Down | miR-16 | Up | SMAD7 | Down | Cell proliferation and apoptosis | Xu and Xu, 2017 |
| (11) | Human | OA | Cartilage, chondrocyte | lncRNA FOXD2-AS1 | Up | miR-206 | Down | CCND1 | Up | Cell proliferation and apoptosis | Cao et al., 2018 |
| (12) | Human | OA | Cartilage, chondrocyte | DANCR | Up | miR-577 | Down | SphK2 | Up | Cell proliferation and apoptosis | Fan et al., 2018 |
| (13) | Human | OA | Cartilage, chondrocyte | HOTAIR | Up | miR-17-5p | Down | FUT2 | Up | Cell proliferation, apoptosis and ECM degradation | Hu et al., 2018 |
| (14) | Human | OA | Cartilage, chondrocyte | XIST | Up | miR-211 | Down | CXCR4 | Up | Cell proliferation and apoptosis | Mohammadi et al., 2018 |
| (15) | Human | OA | Cartilage, chondrocyte | MALAT1 | Up | miR-127-5p | Down | PI3K/Akt | Up | Cell proliferation | Liang et al., 2018 |
| (16) | Mice | OA | Cartilage, chondrocyte | lncRNA-KLF3-AS1 | Up | miR-206 | Down | GIT1 | Up | Cell proliferation and apoptosis | Liu et al., 2018 |
| (17) | Human | OA | Cartilage, chondrocyte | lncRNA CIR | Up | miR-130a | Down | Bim | Up | Cell apoptosis and inflammation | Lu Z. et al., 2019 |
| (18) | Murine | OA | Chondrogenic ATDC5 cells | MALAT1 | Up | miR-19b | Down | Wnt/β-catenin and NF-κB pathways | Up | Cell apoptosis and inflammation | Pan et al., 2018 |
| (19) | Human | OA | Cartilage, chondrocyte | lncRNA SNHG5 | Down | miR-26a | Up | SOX2 | Down | Cell proliferation | Shen et al., 2018 |
| (20) | Human | OA | Human cartilage ATDC5 cells | lncRNA RP11-445H22.4 | Up | miR-301a | Down | CXCR4 | Up | Cell viability, apoptosis and inflammation | Sun et al., 2018 |
| (21) | Human | OA | Cartilage, chondrocyte | lncRNA -p21 | Up | miR-451 | Down | – | – | Cell apoptosis | Tang L. et al., 2018 |
| (22) | Human | OA | Cartilage, chondrocyte | lncRNA TUG1 | Up | miR-195 | Down | MMP13 | Up | ECM degradation | Tang L.P. et al., 2018 |
| (23) | Human | OA | ATDC5 cell | MEG3 | Down | miR-203 | Up | Sirt1 | Up | Cell viability, apoptosis and inflammation | Wang et al., 2018e |
| (24) | Human | OA | Cartilage, chondrocyte | lncRNA DANCR | Up | miR-216a-5p | Down | JAK2/STAT3 signal pathway | Up | Cell proliferation, apoptosis and inflammation | Zhang et al., 2018 |
| (25) | Human | OA | Cartilage, chondrocyte | PVT1 | Up | miR-149 | Down | – | – | Inflammation | Zhao et al., 2018 |
| (26) | Human | OA | Cartilage, chondrocyte | lncRNA DNM3OS | Down | miR-126 | Up | IGF1 | Down | Cell proliferation and apoptosis | Ai and Yu, 2019 |
| (27) | Rats | OA | Cartilage, chondrocyte | MEG3 | Down | miR-93 | Up | TGFBR2 | Down | Cell proliferation, apoptosis and ECM degradation | Chen et al., 2019 |
| (28) | Human | OA | Cartilage, ATDC5 cells | lncRNA-HULC | Down | miR-101 | Up | NF-κB and p38MAPK signaling pathways | Down | Inflammation | Chu et al., 2019 |
| (29) | Human | OA | Synovial fluid, chondrocytes | MCM3AP-AS1 | Up | miR-142-3p | Down | HMGB1 | Up | Cell apoptosis | Gao et al., 2019 |
| (30) | Human | OA | LPS-treated C28/I2 cells | H19 | Up | miR-130a | Down | – | – | Cell viability, apoptosis, and inflammation | Hu et al., 2019 |
| (31) | Human | OA | Cartilage, chondrocyte | TNFSF10 | Up | miR-376-3p | Down | FGFR1 | Up | Cell proliferation, apoptosis, and inflammation | Huang et al., 2019 |
| (32) | Human | OA | Chondrocyte | lncRNA SNHG1 | Down | miR-16-5p | Up | p38MAPK and NF-κB Signaling Pathways | Down | Inflammation | Lei J. et al., 2019 |
| (33) | Human | OA | LPS-treated ATDC5 cells | MIAT | Up | miR-132 | Down | NF-κB and JNK pathways | Up | Cell apoptosis and inflammation | Li et al., 2019a |
| (34) | Rats | OA | LPS-treated chondrocytes | MALAT1 | Down | miR-146a | Up | PI3K | Down | ECM degradation, inflammation and apoptosis | Li et al., 2019b |
| (35) | Human | OA | Cartilage, synoviocytes | lncRNA-ANRIL | Up | miR-122-5p | Down | DUSP4 | Up | Cell proliferation and apoptosis | Li et al., 2019c |
| (36) | Human | OA | LPS-treated ATDC5 cells | PMS2L2 | Down | miR-203 | Up | MCL-1 | Down | Cell viability, apoptosis, and inflammation | Li et al., 2019d |
| (37) | Human | OA | Cartilage, chondrocytes | lncRNA-TM1P3 | Up | miR-22 | Down | ALK1 | Up | ECM degradation | Li et al., 2019e |
| (38) | Human | OA | IL-1β-induced chondrocytes | MALAT1 | Up | miR-145 | Down | ADAMTS5 | Up | ECM degradation | Liu C. et al., 2019 |
| (39) | Murine | OA | LPS-induced ATDC5 cells | THRIL | Up | miR-125b | Down | JAK1/STAT3 and NF-κB pathways | Up | Inflammation | Liu G. et al., 2019 |
| (40) | Human | OA | Cartilages, chondrocytes | PART-1 | Down | miR-590-3p | Up | TGFBR2, Smad3 | Down | Cell viability and apoptosis | Lu C. et al., 2019 |
| (41) | Human | OA | hMSC, cartilage, chondrocytes | HOTTIP | Up | miR-455-3p | Down | CCL3 | Up | Cartilage degradation | Mao et al., 2019 |
| (42) | Human | OA | Chondrocytes | Nespas | Up | miR-291a-3p, miR-196a-5p, miR-23a-3p, miR-24-3p, miR-let-7a-5p | Down | ACSL6 | Up | Lipid metabolism | Park et al., 2019 |
| (43) | Human | OA | Synovial fluid, chondrogenic cell line CHON-001 | CAIF | Down | miR-1246 | Up | IL-6 | Up | Cell apoptosis | Qi et al., 2019 |
| (44) | Human | OA | Cartilage, chondrocyte | MEG3 | Down | miR-361-5p | Up | FOXO1 | Down | Cell proliferation, apoptosis and ECM degradation | Wang A. et al., 2019 |
| (45) | Human, rats | OA | Chondrocyte (Human) cartilage (rat) | XIST | Up | miR-1277-5p | Down | MMP-13, ADAMTS5 | Up | ECM degradation | Wang T. et al., 2019 |
| (46) | Human | OA | Cartilage, chondrocyte | FOXD2-AS1 | Up | miR-27a-3p | Down | TLR4 | Up | Cell proliferation, inflammation and ECM degradation | Wang Y. et al., 2019 |
| (47) | Human | OA | Synovium, chondrocyte | NEAT1 | Down | miR-181a | Up | GPD1L | Down | Cell proliferation, apoptosis and inflammation | Wang Z. et al., 2019 |
| (48) | Human | OA | Cartilages, mesenchymal stem cells (MSCs) | HOTAIRM1-1 | Down | miR-125b | Up | BMPR2 | Down | Cell viability, apoptosis and differentiation | Xiao et al., 2019 |
| (49) | Human | OA | Cartilages, chondrocyte | LINC00341 | Down | miR-141 | Up | YAF2 | Down | Cell apoptosis | Yang Q. et al., 2019 |
| (50) | Murine | OA | LPS-induced ATDC5 cells | lncRNA-ATB | Down | miR-223 | Up | MyD88/NF-κB and p38MAPK pathways | Up | Cell viability, apoptosis and inflammation | Ying et al., 2019 |
| (51) | Mice | OA | IL-6-induced ATDC5 cells | CHRF | Up | miR-146a | Down | / | / | Cell viability, apoptosis and inflammation | Yu et al., 2019 |
| (52) | Human | OA | Cartilage, chondrocyte | H19 | Up | miR-106a-5p | Down | / | / | Cell proliferation and apoptosis | Zhang X. et al., 2019 |
| (53) | Human | OA | Cartilage, chondrocyte | MALAT1 | Up | miR-150-5p | Down | AKT3 | Up | Cell proliferation, apoptosis and ECM degradation | Zhang Y. et al., 2019 |
| (54) | Human | OA | Cartilage, chondrocyte | PART1 | Up | miR-373-3p | Down | SOX4 | Up | Cell proliferation, apoptosis and ECM degradation | Zhu and Jiang, 2019 |
| (55) | Mice | OA | Cartilage, chondrocytes | HOTAIR | Up | miR-20b | Down | PTEN | Up | Cell apoptosis and ECM degradation | Chen Y. et al., 2020 |
| (56) | Human | OA | Cartilage, chondrocytes | HOTAIR | Up | miR-130A-3p | Down | – | – | Cell apoptosis | He and Jiang, 2020 |
| (57) | Human | OA | Cartilage, chondrocyte | GAS5 | Up | miR-34a | Down | Bcl-2 | Up | Cell apoptosis | Ji Q. et al., 2020 |
| (58) | Rat | OA | BMSCs | BLACAT1 | Up | miR-142-5p | Down | – | – | Cell proliferation and differentiation | Ji Y. et al., 2020 |
| (59) | Human | OA | Cartilage, chondrocyte | NEAT1 | Up | miR-16-5p | Up | – | – | Cell proliferation and apoptosis | Li D. et al., 2020 |
| (60) | Human | OA | Cartilage, chondrocyte | XIST | Up | miR-376c-5p | Down | OPN | Up | Cell apoptosis | Li L. et al., 2020 |
| (61) | Human | OA | Cartilage, chondrocyte | NEAT1 | Up | miR-193a-3p | Down | SOX5 | Up | Cell apoptosis, inflammation and ECM degradation | Liu et al., 2020 |
| (62) | Human | OA | Cartilage, chondrocyte | LINC00623 | Down | miR-101 | Up | HRAS | Down | Cell apoptosis, senescence and ECM degradation | Lü et al., 2020 |
| (63) | Rat | OA | Cartilage, chondrocyte | LINC00662 | Down | miR-15b-5p | Up | GPR120 | Down | Cell apoptosis | Lu and Zhou, 2020 |
| (64) | Human | OA | Cartilage, LPS-treated C28/I2 cells | MFI2-AS1 | Up | miR-130a-3p | Down | TCF4 | Up | Cell viability, apoptosis, inflammation and ECM degradation | Luo et al., 2020 |
| (65) | Human | OA | Cartilage, chondrocyte | XIST | Up | miR-142-5p | Down | SGTB | Up | Cell growth, proliferation and apoptosis | Sun P. et al., 2020 |
| (66) | Human | OA | Synovial fluid, chondrocyte | CASC2 | Up | miR-93-5p | Down | – | – | Cell apoptosis | Sun Y. et al., 2020 |
| (67) | Human, Rats | OA | Cartilage (human), chondrocyte (rats) | H19 | Down | miR-106b-5p | Up | TIMP2 | Down | Cell proliferation, migration and ECM degradation | Tan et al., 2020 |
| (68) | Human | OA | Cartilage, chondrocyte | SNHG7 | Down | miR-34a-5p | Up | SYVN1 | Down | Cell proliferation, apoptosis and autophagy | Tian et al., 2020 |
| (69) | Human | OA | Cartilage, chondrocyte | NKILA | Down | miR-145 | Up | SP1 | Down | Cell proliferation, apoptosis and inflammation | Xue et al., 2020 |
| (70) | Human | OA | Synovial fluid, chondrocytes | CTBP1-AS2 | Up | miR-130A | Down | – | – | Cell proliferation | Zhang et al., 2020a |
| (71) | Human | OA | Peripheral Blood, THP-1 cell | IGHCγ1 | Up | miR-6891-3p | Down | TLR4 | Up | Inflammation | Zhang et al., 2020c |
| (72) | Human | OA | Cartilage, chondrocyte | SNHG15 | Down | miR-141-3p | Up | BCL2L13 | Down | Cell proliferation, apoptosis and ECM degradation | Zhang et al., 2020e |
| (73) | Human | OA | Cartilage, chondrocyte | LINC00461 | Up | miR-30a-5p | Down | – | – | Cell proliferation, cell cycle progression, inflammation, and ECM degradation | Zhang et al., 2020g |
| (74) | Human | OA | Cartilage, chondrocyte | OIP5-AS1 | Down | miR-29b-3p | Up | PGRN | Down | Cell proliferation, migration, apoptosis and inflammation | Zhi et al., 2020 |
lncRNA/miRNA/mRNA networks in osteoarthritis.
ACSL6, acyl-CoA synthetase 6; ADAMTSs, a disintegrin and metalloprotease with thrombospondin motifs; ALK1, activin receptor-like kinase 1; ANRIL, antisense non-coding RNA in the INK4 locus; ATB, activated by transforming growth factor beta; BCL2L13, Bcl2-like 13; Bim, B-cell lymphoma 2 interacting mediators of cell death; BMPR2, bone morphogenetic protein receptor 2; BMSCs, bone marrow stromal stem cells; CASC2, Cancer Susceptibility 2; CCND1, Cyclin D1; CHRF, cardiac hypertrophy-related factor; CIR, cartilage injury–related; CXCR4, C-X-C chemokine receptor-4; DANCR, differentiation antagonizing non-protein coding RNA; DNM3OS, dynamin 3 opposite strand; ECM, extracellular matrix; ETV1, Erythroblast transformation-specific translocation variant 1; FGFR1, fibroblast growth factor receptor 1; FUT2, fucosyltransferase 2; GAS5, Growth Arrest-Specific 5; GIT1, G-protein- coupled receptor kinase interacting protein-1; GPD1L, glycerol-3-phosphate dehydrogenase 1-like; GPR120, G protein−coupled receptor 120; HMGB1, high mobility group protein B1; hMSC, human mesenchymal stem cell; HOTAIRM1-1, HOX antisense intergenic RNA myeloid 1 variant 1; HULC, highly up-regulated in liver cancer; IGF1, insulin-like growth factor-1; JAK1, c-Jun N-terminal kinase 1; LPS, lipopolysaccharide; MALAT1, metastasis associated lung adenocarcinoma transcript 1; MCM3AP-AS1, Minichromosome Maintenance Complex Component 3 Associated Protein Antisense RNA 1; MEG3, maternally expressed gene 3; MEG3, maternally expressed gene 3; MFI2-AS1, melanotransferrin antisense RNA; MIAT, myocardial infarction associated transcript; MMP, matrix metalloproteinase; MSCs, mesenchymal stem cells; MSR, mechanical stress; NEAT1, nuclear enriched abundant transcript 1; NF-κB, nuclear factor κB; OA, osteoarthritis; OIP5-AS1, OIP5 antisense RNA 1; OPN, osteopontin; PART-1, prostate androgen-regulated transcript-1; PGRN, progranulin; PI3K, Phosphoinositide 3-kinase; PMS2L2, PMS1 Homolog 2, Mismatch Repair System Component Pseudogene 2; PVT1, plasmacytoma variant translocation 1; SGTB, small glutamine rich tetratricopeptide repeat containing beta; SNHG, small nucleolar RNA host gene; SOX4, SRY-related high-mobility group box 4; SOX5, Sex-determining region Y-box protein 5; STAT3, signal transducer and activator of transcription 3; TCF4, transcription factor 4; TGFBR2, Transforming growth factor-beta receptor type 2; THRIL, TNF and hnRNPL related immune-regulatory lincRNA; TMSB4, Thymosin β-4; TUG1, taurine upregulated gene 1; UCA1, urothelial carcinoma associated 1; XIST, X-inactive-specific transcript; YAF2, YY1-associated factor 2.
Intervertebral Disk Degeneration
The mechanism by which lncRNA and miRNA act on IDD that has been most studied is as follows: lncRNA acts as the sponge of miRNA to modulate target genes (Figure 1). Xi et al. (2017) demonstrated that lncRNA HCG18 was upregulated in the IDD and plays the sponge roles of miR-146a-5p in NP cells. HCG18 is involved in the progression of cell proliferation and apoptosis in NP cells via the miR-146a-5p/TARF6/NF-κB axis. Compared with normal NP tissues, lncRNA SNHG1 (small nucleolar RNA host gene 1) expression was boosted and miR-326, a target gene of SNHG1, was reduced in IDD samples (Tan et al., 2018). Moreover, miR-326 could directly bind with Cyclin D1 (CCND1), and the level of CCND1 in the NP cells markedly increased. Thus, Tan et al. (2018) observed that SNHG1 modulates NP cells proliferation via sponging miR-326 and further regulating CCND1. Another study reported that lncRNA H19 was upregulated in the IDD tissues and could activate Wnt/β-catenin signaling pathway (Wang et al., 2018d). Moreover, miR-326 could directly bind with Cyclin D1 (CCND1), and the level of CCND1 in the NP cells markedly increased. Thus, Tan et al. (2018) observed that SNHG1 modulates NP cells proliferation via sponging miR-326 and further regulating CCND1. Another study reported that lncRNA H19 was upregulated in the IDD tissues and could activate Wnt/β-catenin signaling pathway (Shao et al., 2019). Another research suggested that LINC00641 level increased in NP tissues, whereas miR-153-3p level decreased. ATG5 (autophagy-related gene 5) was a downstream gene of miR-153-3p and upregulated in NP cells (Wang J. et al., 2019). Moreover, LINC00641 could sponge miR-153-3p, and thereby regulate the level of ATG5, cell death and the progression of IDD. Yang Y. et al. (2019) elucidated that lncRNA lincRNA-SLC20A1 (SLC20A1) was overexpressed in IDD patients, and SLC20A1 could induce ECM degradation via sponging miR-31-5p and further modulating the downstream target gene MMP3. Another study established that the level of lncRNA PART1 and mRNA matrix metallopeptidase 2 (MMP2) in NP tissues were significantly higher than those in the control groups, whereas the levels of miR-93 were lower (Gao et al., 2020). Through dual-luciferase reporter assay, they proved that PART1 acts as miR-93 sponges in NP tissues and cells to suppress the expression of miR-93 and to further regulate MMP2. Zheng et al. (2020) showed that MALAT1 was reduced in NP cells, and upregulation of MALAT1 could relieve cell proliferation and apoptosis in vitro and inhibit the degree of INN in vivo. Moreover, they found that MALAT1 plays pivotal roles in IDD through sponging miR-503, and thereby modulate downstream MAPK signaling pathways.
FIGURE 1
Example of altered lncRNA expression patterns and their biological effects in intervertebral disk degeneration. lncRNA, long non-coding RNA; ECM, extracellular matrix; MMP, matrix metallopeptidase; MAPK, mitogen-activated protein kinase; SMAD3, SMAD family member 3; LEF1, lymphoid enhancing factor-1; CCND1, cyclin D1; ADAMTS4, A disintegrin and metalloproteinase with thrombospondin motifs 4; TRAF6, tumor necrosis factor receptor-associated factor 6; Notch1, Notch Receptor 1; Bcl-2, B cell lymphoma 2; ATG5, autophagy-related gene 5.
Several studies indicated that lncRNAs plays roles in IDD by modulating miRNA and their target genes. Wang et al. (2018b) showed that the level of lncRNA-RMRP in degenerated NP tissues was higher than that in normal NP tissues, whereas the expression of miR-206 was lower. They indicated that lncRNA-RMRP could promote cell proliferation via modulating miR-206, thereby regulating downstream target gene MMP13 and ADAMTS4. lncRNA HOTAIR was downregulated in NP tissues and cells, whereas miR-34a expression was negatively correlated with HOTAIR and the expression of Bcl-2 was positively connected with HOTAIR (Yu et al., 2018). HOTAIR could inhibit NP cell apoptosis through regulating miR-34a/Bcl-2 axis. A study found that LINC00958 and mRNA SMAD3 were upregulated in NP tissues, whereas miR-203 was downregulated. Ectopic expression of miR-203 could suppress cell growth and ECM degradation (Zhao et al., 2019). Therefore, LINC00958 participates in the cell process by regulating miR-203 and SMAD3. Another study reported that the expression levels of LINC01121 and MMP-16 significantly increased in NP cells, whereas the level of miR-150-5p decreased (Chen X. et al., 2020). They demonstrated that LINC01121 could enhance the cell process of IDD, such as cell growth, ECM degradation and inflammation by regulating miR-150-5p and MMP-16.
Rheumatoid Arthritis
In RA disease, the most studied mechanism of lncRNA and miRNA is that lncRNA acts as the miRNA sponge to modulate downstream genes (Table 2). lncRNA PVT1 (plasmacytoma variant translocation 1) and SCUBE2 (signal peptide-CUB-EGF-like containing protein 2) were upregulated, whereas miR-543 was downregulated in synovial tissues of RA rats and patients (Wang et al., 2020). Wang et al. (2020) found that the overexpression of PVT1 or the suppression of miR-543 elevated the level of SCUBE2. Moreover, the knockdown of PVT1 could suppress proliferation and induce apoptosis of RA through hindering the expression of SCUBE2 by sponging miR-543 (Wang et al., 2020). lncRNA LINC-PINT (long intergenic non-protein encoding long-chain RNA p53-induced transcript) was reduced in RA tissues and cells (Wang and Zhao, 2020). Through bioinformatics techniques and RNA Binding Protein Immunoprecipitation (RIP) assay, they found that miR-155-5p could interact with LINC-PINT, and SOCS1 was the target mRNA of miR-155-5p. LINC-PINT could inhibit cell proliferation and invasion via sponging miR-155-5p and regulating the level of SOCS1. Yan et al. (2019) revealed that the level of lncRNA HIX003209 in the peripheral blood mononuclear cells (PBMCs) and macrophages of RA samples and the expression of TLR4 was positively correlated with HIX003209. lncRNA HIX003209 directly targeted miR-6089 and was involved in the regulation of inflammation through acting as miR-6089 sponge via the TLR4/NF-κB signaling pathway.
TABLE 2
| Species | Diseases | Region | lncRNA | Change | miRNA | Expression | Target gene | Change | Functions | References | |
| (1) | Rat | RA | Synovial tissues | PVT1 | Up | miR-543 | Down | SCUBE2 | Up | Cell proliferation and apoptosis | Wang et al., 2020 |
| (2) | Human | RA | Synovial tissues | LINC-PINT | Down | miR-155-5p | Up | SOCS1 | Down | Cell proliferation and invasion | Wang and Zhao, 2020 |
| (3) | Human | RA | Serum | HIX003209 | Up | miR-6089 | Down | TLR4 | Up | Inflammation | Yan et al., 2019 |
| (4) | Human | AS | Serum, fibroblast-like synovial cells | lncRNA MEG3 | Down | miR-146a | Up | – | – | Inflammation | Li Y. et al., 2020 |
| (5) | Human | AS | Peripheral blood mononuclear cells | H19 | Up | miR675-5p/miR22-5p | miR675-5p up; miR22-5p down | VDR | Up | Inflammation | Zhang et al., 2020f |
lncRNA/miRNA/mRNA networks in rheumatoid arthritis and ankylosing spondylitis.
AS, ankylosing spondylitis; MEG3, maternally expressed gene 3; PINT, p53-induced transcript; PVT1, plasmacytoma variant translocation 1; RA, rheumatoid arthritis; SCUBE2, signal peptide-CUB-EGF-like containing protein 2; SOCS1, cytokine signaling 1.
Ankylosing Spondylitis
That lncRNA acts as the sponge of miRNA to modulate target genes is the most studied mechanism of lncRNA and miRNA acting on AS (Table 2). Li Y. et al. (2020) reported the role of MEG3 (maternally expressed gene 3) in the inflammation of AS. They observed that the expression level of MEG3 in the serum of AS patients was significantly downregulated compared with that in normal people, and MEG3 could inhibit inflammatory responses. However, the expression of miR-146a was upregulated in the AS patients and miR-146a could directly bind with MEG3 (Li Y. et al., 2020). Li Y. et al. (2020) assumed that MEG3 may played a vital role in the repression of inflammation factors in AS through sponging miR-146a, thereby exploring a novel potential treatment target for AS patients. Zhang et al. (2020f) found that lncRNA H19 was highly expressed in the AS patients and elevated the expression level of IL-17A and IL-23 inflammation factors. H19 could directly modulate miR-22-5p and miR-675-5p, and VDR (vitamin D receptor) was the target mRNAs of these two miRNAs. Among them, the level of miR-22-5p was negatively correlated with H19, while miR-675-5p and VDR was positively with H19 in AS patients. H19 plays regulatory roles in inflammatory reaction in AS through binding with VDR by sponging miR-22-5p and interacting with miR-675-5p (Zhang et al., 2020f).
Interactions Among circRNA, miRNA, and mRNA in Degenerative Musculoskeletal Diseases
Osteoarthritis
Circular RNAs acting as miRNA sponges is the one of the most studied mechanisms (Figure 2). Compared with normal cartilage, circRNA-CER (circRNA_100876) was overexpressed and increased with IL-1 (interleukin-1) and TNF-α (tumor necrosis factor-alpha) in OA chondrocytes. circRNA-CER regulated matrix-degrading matrix metalloproteinase (MMP)-13 expression to participated in the process of chondrocyte ECM degradation by sponging miR-136 (Liu et al., 2016b). According to the research of Zhou et al. (2018), overexpressed circRNA_Atp9b sponge miR-138-5p and then mediate ECM catabolism and inflammation to regulates OA progression in chondrocytes by targeting MMP13. circ_0136474 was also verified by the research of Li et al. (2019f) to sponge miR-127-5p to regulate MMP13 in human OA chondrocytes, then, it suppressed cell proliferation and enhanced cell apoptosis during OA progression. The results were in line with those obtained in a study performed by Zhou Z.B. et al. (2019), who found that circRNA.33186/miR-127-5p/MMP13 axis contributes to OA pathogenesis. Furthermore, circSERPINE2 overexpression could slow down the pace of human chondrocytes apoptosis and promote ECM anabolism by sponging miR-1271-5p and thereby targeting ERG (E26 transformation-specific-related gene) to alleviate OA (Shen et al., 2019). In OA blood samples, the downregulation of ciRS-7 and the upregulation of miR-7 were observed (Zhou X. et al., 2019). ciRS-7 was verified to act as a miR-7 sponge to mediate OA progression. Increased cirM3 expression in OA cartilage tissue and cells could serve as a sponge of miR-296-5p to slow down the proliferation and differentiation of OA chondrocytes, thus involving in regulating the occurrence and development of OA chondrocytes (Ni et al., 2020). The overexpression of circRNA-CDR1as regulated OA progression via reducing Col II level but increased IL-6 and MMP13 contents to modulate inflammation and ECM metabolism by sponging miR-641 (Zhang et al., 2020d).
FIGURE 2
Example of altered circRNA expression patterns and their biological effects in osteoarthritis. circRNA, circular RNA; ECM, extracellular matrix; MMP, matrix metallopeptidase; NAMPT, Nicotinamide phosphoribosyltransferase; COX-2, cyclooxygenase-2; IL-6, interleukin-6; Col II, type II collagen; ERG, E26 transformation-specific-related gene; BAX, BCL2 associated X, apoptosis regulator; Bcl-2, B cell lymphoma 2; IGF1R, insulin-like growth factor 1 receptor; HIF, hypoxia inducible factor; BMP, bone morphogenetic protein.
Several circRNA studies showed that circRNAs act as ceRNAs to competitively bind to miRNAs in OA. Hsa_circ_0045714 expression was downregulated (Liu et al., 2016b; Li B.F. et al., 2017). Furthermore, Li B.F. et al. (2017) determined that hsa_circ_0045714 promoted the expression of miR-193b target gene IGF1R (insulin-like growth factor 1 receptor) to regulate chondrocytes proliferation, apoptosis and ECM synthesis. Otherwise, hsa_circ_0005105 expression is significantly enhanced in OA chondrocytes and can promote ECM degradation by mediating the expression of miR-26a target NAMPT (Nicotinamide phosphoribosyltransferase) (Wu et al., 2017). In the lipopolysaccharide (LPS)-induced OA cell model, the expression levels of circRNA-UBE2G1 was significantly increased and bound to miR-373 as ceRNAs to aggravate the OA progression by targeting hypoxia-inducible factor (HIF)-1a (Chen G. et al., 2020).
Intervertebral Disk Degeneration
Over the past years, some circRNAs have merged as molecular drivers to serve as miRNA sponges or ceRNAs in circRNA/miRNA/mRNA networks in the pathogenesis of IDD (Figure 3). Compared with normal NP tissues, circVMA21 (hsa_circ_0091702) was downregulated in NP tissues and NP cells in IDD and alleviated NP cell apoptosis by targeting miR-200c and XIAP (X linked inhibitor-of-apoptosis protein) (Cheng et al., 2018). Similarly, circ-GRB10 was downregulated during IDD progression, and competitively bound to miR-328-5p to regulate NP cell apoptosis by targeting erb-b2 receptor tyrosine kinase 2 (ERBB2) in the ErbB signaling pathway (Guo et al., 2018). circRNA_104670 was selected via microarray analysis because of its large multiplier expression in IDD tissues (Song et al., 2018). A study reported that circRNA_104670 acted as a ceRNA that binds to miR-17-3p, downregulated circRNA_104670-suppressed MMP-2 expression through circRNA_104670/miR-17-3p/MMP-2 axis, reduced cell apoptosis and increased ECM formation. According to another microarray assay made by Wang et al. (2018a), they selected circ-4099 among 72 upregulated circRNAs in degenerated NP tissues for further analysis. They demonstrated that circ-4099 competitively sponged miR-616-5p, which reversed the suppression of Sox9 by miR-616-5p. Wang et al. (2018c) verified that circSEMA4B was downregulated in IDD specimens, and circSEMA4B served as a miR-431 sponge to compete with SFRP1 or GSK-3β, which are two inhibitory regulators of Wnt signaling, for miR-431 binding, thereby alleviating IL-1β-induced degenerative process in NP cells. circRNA-CIDN was downregulated during IDD progression and bound to miR-34a-5p as a miRNA sponge. Upregulation of miR-34a-5p repressed SIRT1 (silent mating type information regulation 2 homolog 1) to enhance the compression-induced damage of NP cells (Xiang et al., 2020). circERCC2 was also downregulated in IDD NP tissues and NP cells. Furthermore, circERCC2 was associated with the alleviation of IDD through miR-182-5p/SIRT1 axis by activating mitophagy and inhibiting apoptosis (Xie et al., 2019). The expression of circ-FAM169A in IDD samples was significantly upregulated with enhanced ECM catabolism and suppressed ECM anabolism in NP cells. The overexpressed circ-FAM169A competitively bound to miR-583, thus upregulating BTRC (an inducer of the NF-κB signaling pathway) (Guo et al., 2020). circ-FAM169A promoted IDD development via miR-583/BTRC signaling. In addition, circ_001653 could be another novel therapeutic target for IDD that functions by regulating miR-486-3p expression to upregulate CEMIP (cell migration-inducing hyaluronan binding protein) (Cui and Zhang, 2020). circ_001653 downregulation could potentially promote cell proliferation and ECM synthesis through the miR486-3p/CEMIP axis.
FIGURE 3
Example of altered circRNA expression patterns and their biological effects in intervertebral disk degeneration. circRNA, circular RNA; ECM, extracellular matrix; SIRT1, silent mating type information regulation 2 homolog 1; XIAP, X linked inhibitor of-apoptosis protein; ERBB2, erb-b2 receptor tyrosine kinase 2; MMP, matrix metallopeptidase; Sox9, SRY-Box transcription factor 9; HDAC4, histone deacetylase 4; GSK-3β, glycogen synthase kinase-3β; SFRP1, secreted frizzled-related protein 1; CEMIP, cell migration-inducing hyaluronan binding protein; BTRC, beta-transducin repeat-containing protein.
Human NP tissues and human endplate tissues were collected to detect differentially expressed circRNAs during IDD progression. Xiao et al. (2020) induced circRNA expression profile changes in endplate chondrocytes, and results reported that 17 circRNAs were upregulated and 12 circRNAs were downregulated (with fold changes higher than 1.5). circRNA_0058097 was selected for further analysis. circRNA_0058097 increased the expression of HDAC4 (histone deacetylase 4) by sponging miR-365a-5p, which intensified the morphological changes of endplate chondrocytes, and aggravated endplate cartilage and ECM degradation.
Rheumatoid Arthritis and Ankylosing Spondylitis
Rheumatoid arthritis and AS are both characterized by chronic inflammatory disease (van der Heijde et al., 2019; Zhou Y. et al., 2019). However, only a limited number of studies have been conducted on circRNAs in RA and AS (Table 3). Li B. et al. (2018) identified circRNAs in RA synovial tissues and suggested that hsa_circ_0001859 regulated ATF2 expression by competitively sponging miR-204/211. Knockdown of hsa_circ_0001859 suppressed ATF2 expression and decreased inflammatory activity. Hsa_circ_0001859/miR-204/211/ATF2 axis may be used as an approach for treating RA. Another circRNA/miRNA/mRNA network study in RA was conducted by Yang J. et al. (2020), They reported that circRNA_09505 is upregulated in PBMCs from RA patients and mice. The knockdown of circRNA_09505 inhibits macrophage proliferation and alleviates arthritis and inflammation. miR-6089 functions as a ceRNA that is being competitively sponged by circRNA_09505 to regulated macrophage inflammatory response. Furthermore, circRNA_09505 was detected to promote AKT1 expression, which is a direct target of miR-6089, to mediate IκBα/NF-κB signaling pathway. To sum up, circRNA_09505 can sponge miR-6089 and regulate inflammation via miR-6089/AKT1/NF-κB axis in arthritis mice model. Combined with RNA-seq data and RT-qPCR validation of PBMCs from RA patients, the results of Ouyang et al. (2017) showed several upregulated circRNAs (circRNA_101873, circRNA_003524, circRNA_104871, and circRNA_103047), and Wen et al. (2020) proved three upregulated hsa-circRNAs (hsa_circ_0001200, hsa_circ_0001566, and hsa_circ_0003972) and one downregulated hsa_circRNAs (hsa_circ_0008360), but without downstream gene detection to establish circRNA/miRNA/mRNA networks.
TABLE 3
| Species | Diseases | Region | circRNA | Change | miRNA | Change | Target gene | Change | Functions | References | |
| (1) | Human | RA | Synovial tissues | hsa_circ_0001859 | Up | miR-204/211 | Down | ATF2 | Up | Inflammation | Li B. et al., 2018 |
| (2) | Mice | RA | Peripheral blood mononuclear cells | circRNA_09505 | Up | miR-6089 | Down | AKT1/NF-κB signaling pathway | Up | Inflammation | Yang J. et al., 2020 |
circRNA/miRNA/mRNA networks in rheumatoid arthritis.
AKT1, threonine kinase 1; ATF2, activating transcription factor 2; NF-κB: nuclear factor κB; RA, rheumatoid arthritis.
At present, studies on circRNA and miRNA interaction mechanism on AS are lacking. The roles of circRNAs in AS remain unclear. Only one profiling and bioinformatics analysis showed differentially expressed circRNAs in AS patients (sampled form spinal ligament tissues), reported the presence of 57 upregulated circRNAs and 66 downregulated circRNAs in AS spinal ligament tissues (Kou et al., 2020).
Taken together, the study about the interactions among circRNA, miRNA and mRNA in RA and AS may have a great clinical prospect.
Conclusion and Future Prospect
Recent advances in gene expression of lncRNAs and circRNAs, coupled with the ability to interact with the miRNA, mRNA or signaling pathway, have started to expose the different molecular consequence associated with RNA transcriptions and the roles they play in the development of MSDDs (including OA, IDD, RA, and AS) that involve chondrocyte proliferation and apoptosis, ECM degradation and PBMCs inflammation. The effects of ncRNA/circRNA-miRNA-mRNA axis on MSDD progression elucidated their contribution to the dynamic cellular processes and provided the potential OA, IDD, RA and AS therapeutic strategies. The altered expression of lncRNAs or circRNAs refers to diverse biological processes of MSDD, thereby indicating that lncRNAs/circRNAs may be developed as biomarkers and therapeutic targets. Despite the large numbers of ncRNAs, including lncRNAs and circRNAs, determined to be differentially expressed during these pathogenic processes, only a small portion of them has been elucidated. Research on MSDD pathogenesis, especially on RA and AS, is still in its infancy and major knowledge gaps remain to be filled. Therefore, the interactions among lncRNA/circRNA, miRNA and mRNA in MSDD to present the potential pathogenesis is required. Further studies are needed to explore the mutual regulatory mechanisms between lncRNA/circRNA regulation and effective therapeutic interventions in the pathology of MSDD.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Statements
Author contributions
X-QW and P-JC: conceptualization and methodology. J-BG, XS, Y-MC, and ZY: investigation. Y-LZ and GS: writing – original draft preparation and writing – review and editing. All authors contributed to the article and approved the submitted version.
Funding
This work was supported by the National Natural Science Foundation of China (81871844); Shuguang Program supported by Shanghai Education Development Foundation and Shanghai Municipal Education Commission (18SG48); the Shanghai Municipal Commission of Health and Family Planning (201840346); the Shanghai Key Lab of Human Performance (Shanghai University of Sport) (11DZ2261100); and Shanghai Frontiers Science Research Base of Exercise and Metabolic Health.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1
AbbasifardM.KamiabZ.Bagheri-HosseinabadiZ.SadeghiI. (2020). The role and function of long non-coding RNAs in osteoarthritis.Exp. Mol. Pathol.114:104407. 10.1016/j.yexmp.2020.104407
2
AiD.YuF. (2019). LncRNA DNM3OS promotes proliferation and inhibits apoptosis through modulating IGF1 expression by sponging MiR-126 in CHON-001 cells.Diagn. Pathol.14:106.
3
BeermannJ.PiccoliM. T.ViereckJ.ThumT. (2016). Non-coding RNAs in development and disease: background, mechanisms, and therapeutic approaches.Physiol. Rev.961297–1325. 10.1152/physrev.00041.2015
4
CaoL.WangY.WangQ.HuangJ. (2018). LncRNA FOXD2-AS1 regulates chondrocyte proliferation in osteoarthritis by acting as a sponge of miR-206 to modulate CCND1 expression.Biomed. Pharmacother.1061220–1226. 10.1016/j.biopha.2018.07.048
5
ChenG.LiuT.YuB.WangB.PengQ. (2020). CircRNA-UBE2G1 regulates LPS-induced osteoarthritis through miR-373/HIF-1a axis.Cell Cycle191696–1705. 10.1080/15384101.2020.1772545
6
ChenH.QiJ.BiQ.ZhangS. (2017). Expression profile of long noncoding RNA (HOTAIR) and its predicted target miR-17-3p in LPS-induced inflammatory injury in human articular chondrocyte C28/I2 cells.Int. J. Clin. Exp. Pathol.109146–9157.
7
ChenK.ZhuH.ZhengM. Q.DongQ. R. (2019). LncRNA MEG3 inhibits the degradation of the extracellular matrix of chondrocytes in osteoarthritis via targeting miR-93/TGFBR2 axis.Cartilage1947603519855759. 10.1177/1947603519855759[Published online ahead of print]
8
ChenW. K.YuX. H.YangW.WangC.HeW. S.YanY. G.et al (2017). lncRNAs: novel players in intervertebral disc degeneration and osteoarthritis.Cell Prolif.50:e12313. 10.1111/cpr.12313
9
ChenX.LiZ.XuD.LiS. (2020). LINC01121 induced intervertebral disc degeneration via modulating miR-150-5p/MMP16 axis.J. Gene Med.22:e3231.
10
ChenY.HuangJ.TangC.ChenX.YinZ.HengB. C.et al (2017). Small molecule therapeutics for inflammation-associated chronic musculoskeletal degenerative diseases: past, present and future.Exp. Cell Res.3591–9. 10.1016/j.yexcr.2017.07.027
11
ChenY.ZhangL.LiE.ZhangG.HouY.YuanW.et al (2020). Long-chain non-coding RNA HOTAIR promotes the progression of osteoarthritis via sponging miR-20b/PTEN axis.Life Sci.253:117685. 10.1016/j.lfs.2020.117685
12
ChengX.ZhangL.ZhangK.ZhangG.HuY.SunX.et al (2018). Circular RNA VMA21 protects against intervertebral disc degeneration through targeting miR-200c and X linked inhibitor-of-apoptosis protein.Ann. Rheum. Dis.77770–779. 10.1136/annrheumdis-2017-212056
13
ChuP.WangQ.WangZ.GaoC. (2019). Long non-coding RNA highly up-regulated in liver cancer protects tumor necrosis factor-alpha-induced inflammatory injury by down-regulation of microRNA-101 in ATDC5 cells.Int. Immunopharmacol.72148–158. 10.1016/j.intimp.2019.04.004
14
CooperN. A.ScavoK. M.StricklandK. J.TipayamongkolN.NicholsonJ. D.BewyerD. C.et al (2016). Prevalence of gluteus medius weakness in people with chronic low back pain compared to healthy controls.Eur. Spine J.251258–1265. 10.1007/s00586-015-4027-6
15
CuiS.ZhangL. (2020). circ_001653 silencing promotes the proliferation and ECM synthesis of NPCs in IDD by downregulating miR-486-3p-mediated CEMIP.Mol. Ther. Nucleic Acids20385–399. 10.1016/j.omtn.2020.01.026
16
DengK. Y.WangH.GuoX. Q.XiaJ. Z. (2016). The cross talk between long, non-coding RNAs and microRNAs in gastric cancer.Acta Biochim. Biophys. Sin.48111–116. 10.1093/abbs/gmv120
17
FaghihiM. A.ZhangM.HuangJ.ModarresiF.Van Der BrugM. P.NallsM. A.et al (2010). Evidence for natural antisense transcript-mediated inhibition of microRNA function.Genome Biol.11:R56.
18
FanX.YuanJ.XieJ.PanZ.YaoX.SunX.et al (2018). Long non-protein coding RNA DANCR functions as a competing endogenous RNA to regulate osteoarthritis progression via miR-577/SphK2 axis.Biochem. Biophys. Res. Commun.500658–664. 10.1016/j.bbrc.2018.04.130
19
FontanaG.SeeE.PanditA. (2015). Current trends in biologics delivery to restore intervertebral disc anabolism.Adv. Drug Deliv. Rev.84146–158. 10.1016/j.addr.2014.08.008
20
GaoD.HaoL.ZhaoZ. (2020). Long non-coding RNA PART1 promotes intervertebral disc degeneration through regulating the miR-93/MMP2 pathway in nucleus pulposus cells.Int. J. Mol. Med.46289–299.
21
GaoY.ZhaoH.LiY. (2019). LncRNA MCM3AP-AS1 regulates miR-142-3p/HMGB1 to promote LPS-induced chondrocyte apoptosis.BMC Musculoskelet. Disord.20:605. 10.1186/s12891-019-2967-4
22
GuoW.MuK.ZhangB.SunC.ZhaoL.DongZ. Y.et al (2020). The circular RNA FAM169A functions as a competitive endogenous RNA and regulates intervertebral disc degeneration by targeting miR-583 and BTRC.Cell Death Dis.11:315.
23
GuoW.ZhangB.MuK.FengS. Q.DongZ. Y.NingG. Z.et al (2018). Circular RNA GRB10 as a competitive endogenous RNA regulating nucleus pulposus cells death in degenerative intervertebral disk.Cell Death Dis.9:319.
24
HaqueS.HarriesL. W. (2017). Circular RNAs (circRNAs) in health and disease.Genes8:353. 10.3390/genes8120353
25
HeB.JiangD. (2020). HOTAIR-induced apoptosis is mediated by sponging miR-130a-3p to repress chondrocyte autophagy in knee osteoarthritis.Cell Biol. Int.44524–535. 10.1002/cbin.11253
26
HeL.ManC.XiangS.YaoL.WangX.FanY. (2021). Circular RNAs’ cap-independent translation protein and its roles in carcinomas.Mol. Cancer20:119.
27
HuJ.WangZ.ShanY.PanY.MaJ.JiaL. (2018). Long non-coding RNA HOTAIR promotes osteoarthritis progression via miR-17-5p/FUT2/β-catenin axis.Cell Death Dis.9:711.
28
HuY.LiS.ZouY. (2019). Knockdown of LncRNA H19 relieves LPS-induced damage by modulating miR-130a in osteoarthritis.Yonsei. Med. J.60381–388. 10.3349/ymj.2019.60.4.381
29
HuangB.YuH.LiY.ZhangW.LiuX. (2019). Upregulation of long noncoding TNFSF10 contributes to osteoarthritis progression through the miR-376-3p/FGFR1 axis.J. Cell Biochem.12019610–19620. 10.1002/jcb.29267
30
HuangY. (2018). The novel regulatory role of lncRNA-miRNA-mRNA axis in cardiovascular diseases.J. Cell Mol. Med.225768–5775. 10.1111/jcmm.13866
31
HunterD. J.Bierma-ZeinstraS. (2019). Osteoarthritis.Lancet3931745–1759.
32
HuoJ. Z.JiX. H.SuZ. Y.ShangP.GaoF. (2018). Association of ADAMTS4 and ADAMTS5 polymorphisms with musculoskeletal degenerative diseases: a systematic review and meta-analysis.Biosci. Rep.38:BSR20181619.
33
IwakuraT.InuiA.ReddiA. H. (2013). Stimulation of superficial zone protein accumulation by hedgehog and Wnt signaling in surface zone bovine articular chondrocytes.Arthritis Rheum.65408–417.
34
JiQ.QiaoX.LiuY.WangD.YanJ. (2020). Silencing of long-chain non-coding RNA GAS5 in osteoarthritic chondrocytes is mediated by targeting the miR-34a/Bcl-2 axis.Mol. Med. Rep.211310–1319.
35
JiY.FangQ. Y.WangS. N.ZhangZ. W.HouZ. J.LiJ. N.et al (2020). Lnc-RNA BLACAT1 regulates differentiation of bone marrow stromal stem cells by targeting miR-142-5p in osteoarthritis.Eur. Rev. Med. Pharmacol. Sci.242893–2901.
36
JiangS. D.LuJ.DengZ. H.LiY. S.LeiG. H. (2017). Long noncoding RNAs in osteoarthritis.Joint Bone Spine84553–556.
37
KouJ.LiuG.LiuX.LiT.WeiY.SunY.et al (2020). Profiling and bioinformatics analysis of differentially expressed circRNAs in spinal ligament tissues of patients with ankylosing spondylitis.BioMed Res. Int.2020:7165893.
38
KulcheskiF. R.ChristoffA. P.MargisR. (2016). Circular RNAs are miRNA sponges and can be used as a new class of biomarker.J. Biotechnol.23842–51. 10.1016/j.jbiotec.2016.09.011
39
LeeR. C.FeinbaumR. L.AmbrosV. (1993). The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14.Cell75843–854. 10.1016/0092-8674(93)90529-y
40
LeiB.XuanX. Y.FanW. P. (2019). Progress in research on role of CircRNA in autoimmune diseases.Chin. J. Biol.32347–350.
41
LeiJ.FuY.ZhuangY.ZhangK.LuD. (2019). LncRNA SNHG1 alleviates IL-1β-induced osteoarthritis by inhibiting miR-16-5p-mediated p38 MAPK and NF-κB signaling pathways.Biosci. Rep.39:BSR20191523.
42
LiB.ChenD. (2019). Degenerative musculoskeletal diseases: pathology and treatments.J. Orthop. Translat.171–2. 10.1016/j.jot.2019.05.001
43
LiB.LiN.ZhangL.LiK.XieY.XueM.et al (2018). Hsa_circ_0001859 Regulates ATF2 expression by functioning as an MiR-204/211 sponge in human rheumatoid arthritis.J. Immunol. Res.2018:9412387.
44
LiB. F.ZhangY.XiaoJ.WangF.LiM.GuoX. Z.et al (2017). Hsa_circ_0045714 regulates chondrocyte proliferation, apoptosis and extracellular matrix synthesis by promoting the expression of miR-193b target gene IGF1R.Hum. Cell30311–318. 10.1007/s13577-017-0177-7
45
LiC.PanS.SongY.LiY.QuJ. (2019a). Silence of lncRNA MIAT protects ATDC5 cells against lipopolysaccharides challenge via up-regulating miR-132.Artif. Cells Nanomed. Biotechnol.472521–2527. 10.1080/21691401.2019.1626410
46
LiD.SunY.WanY.WuX.YangW. (2020). LncRNA NEAT1 promotes proliferation of chondrocytes via down-regulation of miR-16-5p in osteoarthritis.J. Gene Med.22:e3203.
47
LiH.XieS.LiH.ZhangR.ZhangH. (2019b). LncRNA MALAT1 mediates proliferation of LPS treated-articular chondrocytes by targeting the miR-146a-PI3K/Akt/mTOR axis.Life Sci.254:116801. 10.1016/j.lfs.2019.116801
48
LiH. Z.LinZ.XuX. H.LinN.LuH. D. (2018). The potential roles of circRNAs in osteoarthritis: a coming journey to find a treasure.Biosci. Rep.38:BSR20180542.
49
LiL.LvG.WangB.KuangL. (2020). XIST/miR-376c-5p/OPN axis modulates the influence of proinflammatory M1 macrophages on osteoarthritis chondrocyte apoptosis.J. Cell Physiol.235281–293. 10.1002/jcp.28968
50
LiX.HuangT. L.ZhangG. D.JiangJ. T.GuoP. Y. (2019c). LncRNA ANRIL impacts the progress of osteoarthritis via regulating proliferation and apoptosis of osteoarthritis synoviocytes.Eur. Rev. Med. Pharmacol. Sci.239729–9737.
51
LiX.YuM.ChenL.SunT.WangH.ZhaoL.et al (2019d). LncRNA PMS2L2 protects ATDC5 chondrocytes against lipopolysaccharide-induced inflammatory injury by sponging miR-203.Life Sci.217283–292. 10.1016/j.lfs.2018.12.020
52
LiY.LiS.LuoY.LiuY.YuN. (2017). LncRNA PVT1 regulates chondrocyte apoptosis in osteoarthritis by acting as a sponge for miR-488-3p.DNA Cell Biol.36571–580. 10.1089/dna.2017.3678
53
LiY.LiZ.LiC.ZengY.LiuY. (2019e). Long noncoding RNA TM1P3 is involved in osteoarthritis by mediating chondrocyte extracellular matrix degradation.J. Cell Biochem.12012702–12712. 10.1002/jcb.28539
54
LiY.ZhangS.ZhangC.WangM. (2020). LncRNA MEG3 inhibits the inflammatory response of ankylosing spondylitis by targeting miR-146a.Mol. Cell Biochem.46617–24. 10.1007/s11010-019-03681-x
55
LiY. F.LiS. H.LiuY.LuoY. T. (2017). Long noncoding RNA CIR promotes chondrocyte extracellular matrix degradation in osteoarthritis by acting as a sponge for Mir-27b.Cell Physiol. Biochem.43602–610. 10.1159/000480532
56
LiZ.LiX.JiangC.QianW.TseG.ChanM. T. V.et al (2018). Long non-coding RNAs in rheumatoid arthritis.Cell Prolif.51:e12404.
57
LiZ.YuanB.PeiZ.ZhangK.DingZ.ZhuS.et al (2019f). Circ_0136474 and MMP-13 suppressed cell proliferation by competitive binding to miR-127-5p in osteoarthritis.J. Cell Mol. Med.236554–6564. 10.1111/jcmm.14400
58
LiangJ.XuL.ZhouF.LiuA. M.GeH. X.ChenY. Y.et al (2018). MALAT1/miR-127-5p regulates osteopontin (OPN)-mediated proliferation of human chondrocytes through PI3K/Akt pathway.J. Cell Biochem.119431–439. 10.1002/jcb.26200
59
LiuC.RenS.ZhaoS.WangY. (2019). LncRNA MALAT1/MiR-145 adjusts IL-1β-induced chondrocytes viability and cartilage matrix degradation by regulating ADAMTS5 in human osteoarthritis.Yonsei Med. J.601081–1092. 10.3349/ymj.2019.60.11.1081
60
LiuF.LiuX.YangY.SunZ.DengS.JiangZ.et al (2020). NEAT1/miR-193a-3p/SOX5 axis regulates cartilage matrix degradation in human osteoarthritis.Cell Biol Int44947–957. 10.1002/cbin.11291
61
LiuG.WangY.ZhangM.ZhangQ. (2019). Long non-coding RNA THRIL promotes LPS-induced inflammatory injury by down-regulating microRNA-125b in ATDC5 cells.Int. Immunopharmacol.66354–361. 10.1016/j.intimp.2018.11.038
62
LiuQ.HuX.ZhangX.DaiL.DuanX.ZhouC.et al (2016a). The TMSB4 pseudogene LncRNA functions as a competing endogenous RNA to promote cartilage degradation in human osteoarthritis.Mol. Ther.241726–1733. 10.1038/mt.2016.151
63
LiuQ.ZhangX.HuX.DaiL.FuX.ZhangJ.et al (2016b). Circular RNA related to the chondrocyte ECM regulates MMP13 expression by functioning as a MiR-136 ‘Sponge’ in human cartilage degradation.Sci. Rep.6:22572.
64
LiuY.LiZ.ZhangM.ZhouH.WuX.ZhongJ.et al (2021). Rolling-translated EGFR variants sustain EGFR signaling and promote glioblastoma tumorigenicity.Neuro. Oncol.23743–756. 10.1093/neuonc/noaa279
65
LiuY.LinL.ZouR.WenC.WangZ.LinF. (2018). MSC-derived exosomes promote proliferation and inhibit apoptosis of chondrocytes via lncRNA-KLF3-AS1/miR-206/GIT1 axis in osteoarthritis.Cell Cycle172411–2422. 10.1080/15384101.2018.1526603
66
LoefM.Van BeestS.KroonF. P. B.BloemJ. L.DekkersO. M.ReijnierseM.et al (2018). Comparison of histological and morphometrical changes underlying subchondral bone abnormalities in inflammatory and degenerative musculoskeletal disorders: a systematic review.Osteoarthritis Cartilage26992–1002. 10.1016/j.joca.2018.05.007
67
LoeserR. F.GoldringS. R.ScanzelloC. R.GoldringM. B. (2012). Osteoarthritis: a disease of the joint as an organ.Arthritis Rheum.641697–1707. 10.1002/art.34453
68
LuC.LiZ.HuS.CaiY.PengK. (2019). LncRNA PART-1 targets TGFBR2/Smad3 to regulate cell viability and apoptosis of chondrocytes via acting as miR-590-3p sponge in osteoarthritis.J. Cell Mol. Med.238196–8205. 10.1111/jcmm.14690
69
LüG.LiL.WangB.KuangL. (2020). LINC00623/miR-101/HRAS axis modulates IL-1β-mediated ECM degradation, apoptosis and senescence of osteoarthritis chondrocytes.Aging (Albany NY)123218–3237. 10.18632/aging.102801
70
LuM.ZhouE. (2020). Long noncoding RNA LINC00662-miR-15b-5p mediated GPR120 dysregulation contributes to osteoarthritis.Pathol. Int.70155–165. 10.1111/pin.12875
71
LuZ.LuoM.HuangY. (2019). lncRNA-CIR regulates cell apoptosis of chondrocytes in osteoarthritis.J. Cell. Biochem.1207229–7237. 10.1002/jcb.27997
72
LuoX.WangJ.WeiX.WangS.WangA. (2020). Knockdown of lncRNA MFI2-AS1 inhibits lipopolysaccharide-induced osteoarthritis progression by miR-130a-3p/TCF4.Life Sci.240:117019. 10.1016/j.lfs.2019.117019
73
MaoG.KangY.LinR.HuS.ZhangZ.LiH.et al (2019). Long non-coding RNA HOTTIP promotes CCL3 expression and induces cartilage degradation by sponging miR-455-3p.Front. Cell Dev. Biol.7:161. 10.3389/fcell.2019.00161
74
MathyN. W.ChenX. M. (2017). Long non-coding RNAs (lncRNAs) and their transcriptional control of inflammatory responses.J. Biol. Chem.29212375–12382. 10.1074/jbc.r116.760884
75
MohammadiA.KellyO. B.FiliceM.KabakchievB.SmithM. I.SilverbergM. S. (2018). Differential expression of microRNAs in peripheral blood mononuclear cells identifies autophagy and TGF-Beta-related signatures aberrantly expressed in inflammatory bowel disease.J. Crohns Colitis12568–581. 10.1093/ecco-jcc/jjy010
76
Moran-MoguelM. C.Petarra-Del RioS.Mayorquin-GalvanE. E.Zavala-CernaM. G. (2018). Rheumatoid arthritis and miRNAs: a critical review through a functional view.J. Immunol. Res.2018:2474529.
77
NiJ. L.DangX. Q.ShiZ. B. (2020). CircPSM3 inhibits the proliferation and differentiation of OA chondrocytes by targeting miRNA-296-5p.Eur. Rev. Med. Pharmacol. Sci.243467–3475.
78
OuyangQ.WuJ.JiangZ.ZhaoJ.WangR.LouA.et al (2017). Microarray expression profile of circular RNAs in peripheral blood mononuclear cells from rheumatoid arthritis patients.Cell Physiol. Biochem.42651–659. 10.1159/000477883
79
PanL.LiuD.ZhaoL.WangL.XinM.LiX. (2018). Long noncoding RNA MALAT1 alleviates lipopolysaccharide-induced inflammatory injury by upregulating microRNA-19b in murine chondrogenic ATDC5 cells.J. Cell Biochem.11910165–10175.
80
PanZ.LiG. F.SunM. L.XieL.LiuD.ZhangQ.et al (2019). MicroRNA-1224 splicing circularRNA-Filip1l in an Ago2-dependent manner regulates chronic inflammatory pain via targeting Ubr5.J. Neurosci.392125–2143. 10.1523/jneurosci.1631-18.2018
81
ParkS.LeeM.ChunC. H.JinE. J. (2019). The lncRNA, Nespas, Is associated with osteoarthritis progression and serves as a potential new prognostic biomarker.Cartilage10148–156. 10.1177/1947603517725566
82
QiK.LinR.XueC.LiuT.WangY.ZhangY.et al (2019). Long non-coding RNA (LncRNA) CAIF is downregulated in osteoarthritis and inhibits LPS-induced interleukin 6 (IL-6) upregulation by downregulation of MiR-1246.Med. Sci. Monit.258019–8024. 10.12659/msm.917135
83
RongD.SunH.LiZ.LiuS.DongC.FuK.et al (2017). An emerging function of circRNA-miRNAs-mRNA axis in human diseases.Oncotarget873271–73281. 10.18632/oncotarget.19154
84
SamartzisD.KarppinenJ.MokF.FongD. Y.LukK. D.CheungK. M. (2011). A population-based study of juvenile disc degeneration and its association with overweight and obesity, low back pain, and diminished functional status.J. Bone Joint Surg. Am.93662–670. 10.2106/jbjs.i.01568
85
Satoshi YamashitaH. A. (2012). miRNA functions in arthritis.Curr. Rheumatol. Rev.898–102. 10.2174/157339712802083786
86
SeeligerC.BalmayorE. R.Van GriensvenM. (2016). miRNAs related to skeletal diseases.Stem Cells Dev.251261–1281. 10.1089/scd.2016.0133
87
ShaoT.HuY.TangW.ShenH.YuZ.GuJ. (2019). The long noncoding RNA HOTAIR serves as a microRNA-34a-5p sponge to reduce nucleus pulposus cell apoptosis via a NOTCH1-mediated mechanism.Gene715:144029. 10.1016/j.gene.2019.144029
88
ShenH.WangY.ShiW.SunG.HongL.ZhangY. (2018). LncRNA SNHG5/miR-26a/SOX2 signal axis enhances proliferation of chondrocyte in osteoarthritis.Acta Biochim. Biophys. Sin. (Shanghai)50191–198. 10.1093/abbs/gmx141
89
ShenS.WuY.ChenJ.XieZ.HuangK.WangG.et al (2019). CircSERPINE2 protects against osteoarthritis by targeting miR-1271 and ETS-related gene.Ann. Rheum. Dis.78826–836. 10.1136/annrheumdis-2018-214786
90
SmolenJ. S.AletahaD.McinnesI. B. (2016). Rheumatoid arthritis.Lancet3882023–2038.
91
SongJ.AhnC.ChunC. H.JinE. J. (2014). A long non-coding RNA, GAS5, plays a critical role in the regulation of miR-21 during osteoarthritis.J. Orthop. Res.321628–1635. 10.1002/jor.22718
92
SongJ.WangH. L.SongK. H.DingZ. W.WangH. L.MaX. S.et al (2018). CircularRNA_104670 plays a critical role in intervertebral disc degeneration by functioning as a ceRNA.Exp. Mol. Med.50:94.
93
SteckE.BoeufS.GablerJ.WerthN.SchnatzerP.DiederichsS.et al (2012). Regulation of H19 and its encoded microRNA-675 in osteoarthritis and under anabolic and catabolic in vitro conditions.J. Mol. Med. (Berl)901185–1195. 10.1007/s00109-012-0895-y
94
SunP.WuY.LiX.JiaY. (2020). miR-142-5p protects against osteoarthritis through competing with lncRNA XIST.J. Gene Med.22:e3158.
95
SunT.YuJ.HanL.TianS.XuB.GongX.et al (2018). Knockdown of long non-coding RNA RP11-445H22.4 alleviates LPS-induced injuries by regulation of MiR-301a in osteoarthritis.Cell Physiol. Biochem.45832–843. 10.1159/000487175
96
SunY.KangS.PeiS.SangC.HuangY. (2020). MiR93-5p inhibits chondrocyte apoptosis in osteoarthritis by targeting lncRNA CASC2.BMC Musculoskelet. Disord.21:26. 10.1186/s12891-019-3025-y
97
TanF.WangD.YuanZ. (2020). The fibroblast-like synoviocyte derived exosomal long non-coding RNA H19 alleviates osteoarthritis progression through the miR-106b-5p/TIMP2 axis.Inflammation431498–1509. 10.1007/s10753-020-01227-8
98
TanH.ZhaoL.SongR.LiuY.WangL. (2018). The long noncoding RNA SNHG1 promotes nucleus pulposus cell proliferation through regulating miR-326 and CCND1.Am. J. Physiol. Cell Physiol.315C21–C27.
99
TangL.DingJ.ZhouG.LiuZ. (2018). LncRNA-p21 promotes chondrocyte apoptosis in osteoarthritis by acting as a sponge for miR-451.Mol. Med. Rep.185295–5301.
100
TangL. P.DingJ. B.LiuZ. H.ZhouG. J. (2018). LncRNA TUG1 promotes osteoarthritis-induced degradation of chondrocyte extracellular matrix via miR-195/MMP-13 axis.Eur. Rev. Med. Pharmacol. Sci.228574–8581.
101
TaurogJ. D.ChhabraA.ColbertR. A. (2016). Ankylosing spondylitis and axial spondyloarthritis.N. Engl. J. Med.3742563–2574.
102
TianF.WangJ.ZhangZ.YangJ. (2020). LncRNA SNHG7/miR-34a-5p/SYVN1 axis plays a vital role in proliferation, apoptosis and autophagy in osteoarthritis.Biol. Res.53:9.
103
van der HeijdeD.BraunJ.DeodharA.BaraliakosX.LandewéR.RichardsH. B.et al (2019). Modified stoke ankylosing spondylitis spinal score as an outcome measure to assess the impact of treatment on structural progression in ankylosing spondylitis.Rheumatology (Oxford, England)58388–400.
104
VerduciL.StranoS.YardenY.BlandinoG. (2019). The circRNA-microRNA code: emerging implications for cancer diagnosis and treatment.Mol. Oncol.13669–680. 10.1002/1878-0261.12468
105
VieiraA. S.DoginiD. B.Lopes-CendesI. (2018). Role of non-coding RNAs in non-aging-related neurological disorders.Braz. J. Med. Biol. Res.51e7566.
106
VinatierC.MerceronC.GuicheuxJ. (2016). Osteoarthritis: from pathogenic mechanisms and recent clinical developments to novel prospective therapeutic options.Drug Discov. Today211932–1937. 10.1016/j.drudis.2016.08.011
107
WangA.HuN.ZhangY.ChenY.SuC.LvY.et al (2019). MEG3 promotes proliferation and inhibits apoptosis in osteoarthritis chondrocytes by miR-361-5p/FOXO1 axis.BMC Med. Genomics12:201. 10.1186/s12920-019-0649-6
108
WangG.BuX.ZhangY.ZhaoX.KongY.MaL.et al (2017). LncRNA-UCA1 enhances MMP-13 expression by inhibiting miR-204-5p in human chondrocytes.Oncotarget891281–91290. 10.18632/oncotarget.20108
109
WangH.HeP.PanH.LongJ.WangJ.LiZ.et al (2018a). Circular RNA circ-4099 is induced by TNF-α and regulates ECM synthesis by blocking miR-616-5p inhibition of Sox9 in intervertebral disc degeneration.Exp. Mol. Med.50:27.
110
WangJ.KongX.HuH.ShiS. (2020). Knockdown of long non-coding RNA PVT1 induces apoptosis of fibroblast-like synoviocytes through modulating miR-543-dependent SCUBE2 in rheumatoid arthritis.J. Orthop. Surg. Res.15:142.
111
WangJ.YanS.YangJ.LuH.XuD.WangZ. (2019). Non-coding RNAs in rheumatoid arthritis: from bench to bedside.Front. Immunol.10:3129.
112
WangJ.ZhaoQ. (2020). LncRNA LINC-PINT increases SOCS1 expression by sponging miR-155-5p to inhibit the activation of ERK signaling pathway in rheumatoid arthritis synovial fibroblasts induced by TNF-α.Int. Immunopharmacol.84:106497. 10.3389/fimmu.2019.03129
113
WangQ.WangW.ZhangF.DengY.LongZ. (2017). NEAT1/miR-181c regulates osteopontin (OPN)-mediated synoviocyte proliferation in osteoarthritis.J. Cell Biochem.1183775–3784. 10.1002/jcb.26025
114
WangT.LiuY.WangY.HuangX.ZhaoW.ZhaoZ. (2019). Long non-coding RNA XIST promotes extracellular matrix degradation by functioning as a competing endogenous RNA of miR-1277-5p in osteoarthritis.Int. J. Mol. Med.44630–642.
115
WangX.PengL.GongX.ZhangX.SunR.DuJ. (2018b). LncRNA-RMRP promotes nucleus pulposus cell proliferation through regulating miR-206 expression.J. Cell Mol. Med.225468–5476. 10.1111/jcmm.13817
116
WangX.WangB.ZouM.LiJ.LüG.ZhangQ.et al (2018c). CircSEMA4B targets miR-431 modulating IL-1β-induced degradative changes in nucleus pulposus cells in intervertebral disc degeneration via Wnt pathway.Biochim. Biophys. Acta Mol. Basis Dis.18643754–3768. 10.1016/j.bbadis.2018.08.033
117
WangX.ZouM.LiJ.WangB.ZhangQ.LiuF.et al (2018d). LncRNA H19 targets miR-22 to modulate H(2) O(2) -induced deregulation in nucleus pulposus cell senescence, proliferation, and ECM synthesis through Wnt signaling.J. Cell Biochem.1194990–5002. 10.1002/jcb.26738
118
WangY.CaoL.WangQ.HuangJ.XuS. (2019). LncRNA FOXD2-AS1 induces chondrocyte proliferation through sponging miR-27a-3p in osteoarthritis.Artif. Cells Nanomed. Biotechnol.471241–1247. 10.1080/21691401.2019.1596940
119
WangZ.ChiX.LiuL.WangY.MeiX.YangY.et al (2018e). Long noncoding RNA maternally expressed gene 3 knockdown alleviates lipopolysaccharide-induced inflammatory injury by up-regulation of miR-203 in ATDC5 cells.Biomed. Pharmacother.100240–249. 10.1016/j.biopha.2018.02.018
120
WangZ.HaoJ.ChenD. (2019). Long noncoding RNA nuclear enriched abundant transcript 1 (NEAT1) regulates proliferation, apoptosis, and inflammation of chondrocytes via the miR-181a/glycerol-3-phosphate dehydrogenase 1-Like (GPD1L) axis.Med. Sci. Monit.258084–8094. 10.12659/msm.918416
121
WenJ.LiuJ.ZhangP.JiangH.XinL.WanL.et al (2020). RNA-seq reveals the circular RNA and miRNA expression profile of peripheral blood mononuclear cells in patients with rheumatoid arthritis.Biosci. Rep.40:BSR20193160.
122
WuY.ZhangY.ZhangY.WangJ. J. (2017). CircRNA hsa_circ_0005105 upregulates NAMPT expression and promotes chondrocyte extracellular matrix degradation by sponging miR-26a.Cell Biol. Int.411283–1289. 10.1002/cbin.10761
123
WuY. G.LuX. X.ShenB.ZengY. (2019). The Therapeutic potential and role of miRNA, lncRNA, and circRNA in osteoarthritis.Curr. Gene Ther.19255–263. 10.2174/1566523219666190716092203
124
XiY.JiangT.WangW.YuJ.WangY.WuX.et al (2017). Long non-coding HCG18 promotes intervertebral disc degeneration by sponging miR-146a-5p and regulating TRAF6 expression.Sci. Rep.7:13234.
125
XiangQ.KangL.WangJ.LiaoZ.SongY.ZhaoK.et al (2020). CircRNA-CIDN mitigated compression loading-induced damage in human nucleus pulposus cells via miR-34a-5p/SIRT1 axis.EBioMedicine53:102679. 10.1016/j.ebiom.2020.102679
126
XiaoL.DingB.XuS.GaoJ.YangB.WangJ.et al (2020). circRNA_0058097 promotes tension-induced degeneration of endplate chondrocytes by regulating HDAC4 expression through sponge adsorption of miR-365a-5p.J. Cell. Biochem.121418–429. 10.1002/jcb.29202
127
XiaoY.YanX.YangY.MaX. L. (2019). Downregulation of long noncoding RNA HOTAIRM1 variant 1 contributes to osteoarthritis via regulating miR-125b/BMPR2 axis and activating JNK/MAPK/ERK pathway.Biomed. Pharmacother.1091569–1577. 10.1016/j.biopha.2018.10.181
128
XieL.HuangW.FangZ.DingF.ZouF.MaX.et al (2019). CircERCC2 ameliorated intervertebral disc degeneration by regulating mitophagy and apoptosis through miR-182-5p/SIRT1 axis.Cell Death Dis.10:751.
129
XuJ.XuY. (2017). The lncRNA MEG3 downregulation leads to osteoarthritis progression via miR-16/SMAD7 axis.Cell Biosci.7:69.
130
XueH.YuP.WangW. Z.NiuY. Y.LiX. (2020). The reduced lncRNA NKILA inhibited proliferation and promoted apoptosis of chondrocytes via miR-145/SP1/NF-κB signaling in human osteoarthritis.Eur. Rev. Med. Pharmacol. Sci.24535–548.
131
YanS.WangP.WangJ.YangJ.LuH.JinC.et al (2019). Long non-coding RNA HIX003209 promotes inflammation by sponging miR-6089 via TLR4/NF-κB signaling pathway in rheumatoid arthritis.Front. Immunol.10:2218. 10.3389/fimmu.2019.02218
132
YangJ.ChengM.GuB.WangJ.YanS.XuD. (2020). CircRNA_09505 aggravates inflammation and joint damage in collagen-induced arthritis mice via miR-6089/AKT1/NF-κB axis.Cell Death Dis.11:833.
133
YangQ.LiX.ZhouY.FuW.WangJ.WeiQ. (2019). A LINC00341-mediated regulatory pathway supports chondrocyte survival and may prevent osteoarthritis progression.J. Cell Biochem.12010812–10820. 10.1002/jcb.28372
134
YangS.ZhangF.MaJ.DingW. (2020). Intervertebral disc ageing and degeneration: The antiapoptotic effect of oestrogen.Ageing Res. Rev.57:100978. 10.1016/j.arr.2019.100978
135
YangY.ZhongZ.ZhaoY.RenK.LiN. (2019). LincRNA-SLC20A1 (SLC20A1) promotes extracellular matrix degradation in nucleus pulposus cells in human intervertebral disc degeneration by targeting the miR-31-5p/MMP3 axis.Int. J. Clin. Exp. Pathol.123632–3643.
136
YeF.GaoG.ZouY.ZhengS.ZhangL.OuX.et al (2019). circFBXW7 inhibits malignant progression by sponging miR-197-3p and encoding a 185-aa protein in triple-negative breast cancer.Mol. Ther. Nucleic Acids1888–98. 10.1016/j.omtn.2019.07.023
137
YingH.WangY.GaoZ.ZhangQ. (2019). Long non-coding RNA activated by transforming growth factor beta alleviates lipopolysaccharide-induced inflammatory injury via regulating microRNA-223 in ATDC5 cells.Int. Immunopharmacol.69313–320. 10.1016/j.intimp.2019.01.056
138
YuC.ShiD.LiZ.WanG.ShiX. (2019). Long noncoding RNA CHRF exacerbates IL-6-induced inflammatory damages by downregulating microRNA-146a in ATDC5 cells.J. Cell Physiol.23421851–21859. 10.1002/jcp.28749
139
YuC. X.SunS. (2018). An emerging role for circular RNAs in osteoarthritis.Yonsei Med. J.59349–355. 10.3349/ymj.2018.59.3.349
140
YuY.ZhangX.LiZ.KongL.HuangY. (2018). LncRNA HOTAIR suppresses TNF-α induced apoptosis of nucleus pulposus cells by regulating miR-34a/Bcl-2 axis.Biomed. Pharmacother.107729–737. 10.1016/j.biopha.2018.08.033
141
YuanW.CheW.JiangY.-Q.YuanF.-L.WangH.-R.ZhengG.-L.et al (2015). Establishment of intervertebral disc degeneration model induced by ischemic sub-endplate in rat tail.Spine J.151050–1059. 10.1016/j.spinee.2015.01.026
142
ZhangG.WuY.XuD.YanX. (2016). Long noncoding RNA UFC1 promotes proliferation of chondrocyte in osteoarthritis by acting as a sponge for miR-34a.DNA Cell Biol.35691–695. 10.1089/dna.2016.3397
143
ZhangH.LiJ.ShaoW.ShenN. (2020a). LncRNA CTBP1-AS2 is upregulated in osteoarthritis and increases the methylation of miR-130a gene to inhibit chondrocyte proliferation.Clin. Rheumatol.393473–3478. 10.1007/s10067-020-05113-4
144
ZhangL.WuH.ZhaoM.ChangC.LuQ. (2020b). Clinical significance of miRNAs in autoimmunity.J. Autoimmun.109:102438. 10.1016/j.jaut.2020.102438
145
ZhangL.ZhangP.SunX.ZhouL.ZhaoJ. (2018). Long non-coding RNA DANCR regulates proliferation and apoptosis of chondrocytes in osteoarthritis via miR-216a-5p-JAK2-STAT3 axis.Biosci. Rep.38:BSR20181228.
146
ZhangP.SunJ.LiangC.GuB.XuY.LuH.et al (2020c). lncRNA IGHCγ1 Acts as a ceRNA to regulate macrophage inflammation via the miR-6891-3p/TLR4 Axis in osteoarthritis.Mediators Inflamm.2020:9743037.
147
ZhangS. B.LinS. Y.LiuM.LiuC. C.DingH. H.SunY.et al (2019). CircAnks1a in the spinal cord regulates hypersensitivity in a rodent model of neuropathic pain.Nat. Commun.10:4119.
148
ZhangW.ZhangC.HuC.LuoC.ZhongB.YuX. (2020d). Circular RNA-CDR1as acts as the sponge of microRNA-641 to promote osteoarthritis progression.J. Inflamm. (Lond)178.
149
ZhangX.HuangC. R.PanS.PangY.ChenY. S.ZhaG. C.et al (2020e). Long non-coding RNA SNHG15 is a competing endogenous RNA of miR-141-3p that prevents osteoarthritis progression by upregulating BCL2L13 expression.Int. Immunopharmacol.83:106425. 10.1016/j.intimp.2020.106425
150
ZhangX.JiS.CaiG.PanZ.HanR.YuanY.et al (2020f). H19 Increases IL-17A/IL-23 releases via regulating VDR by interacting with miR675-5p/miR22-5p in ankylosing spondylitis.Mol. Ther. Nucleic Acids19393–404. 10.1016/j.omtn.2019.11.025
151
ZhangX.LiuX.NiX.FengP.WangY. (2019). Long non-coding RNA H19 modulates proliferation and apoptosis in osteoarthritis via regulating miR-106a-5p.J. Biosci.44:128.
152
ZhangY.MaL.WangC.WangL.GuoY.WangG. (2020g). Long noncoding RNA LINC00461 induced osteoarthritis progression by inhibiting miR-30a-5p.Aging (Albany NY)124111–4123. 10.18632/aging.102839
153
ZhangY.WangF.ChenG.HeR.YangL. (2019). LncRNA MALAT1 promotes osteoarthritis by modulating miR-150-5p/AKT3 axis.Cell Biosci.9:54.
154
ZhaoC. Q.JiangL. S.DaiL. Y. (2006). Programmed cell death in intervertebral disc degeneration.Apoptosis112079–2088. 10.1007/s10495-006-0290-7
155
ZhaoK.ZhangY.YuanH.ZhaoM.ZhaoD. (2019). Long noncoding RNA LINC00958 accelerates the proliferation and matrix degradation of the nucleus pulposus by regulating miR-203/SMAD3.Aging (Albany NY)1110814–10825. 10.18632/aging.102436
156
ZhaoY.ZhaoJ.GuoX.SheJ.LiuY. (2018). Long non-coding RNA PVT1, a molecular sponge for miR-149, contributes aberrant metabolic dysfunction and inflammation in IL-1β-simulated osteoarthritic chondrocytes.Biosci. Rep.38:BSR20180576.
157
ZhengH.WangT.LiX.HeW.GongZ.LouZ.et al (2020). LncRNA MALAT1 exhibits positive effects on nucleus pulposus cell biology in vivo and in vitro by sponging miR-503.BMC Mol. Cell Biol.21:23.
158
ZhiL.ZhaoJ.ZhaoH.QingZ.LiuH.MaJ. (2020). Downregulation of LncRNA OIP5-AS1 induced by IL-1b aggravates osteoarthritis via regulating miR-29b-3p/PGRN.Cartilage1947603519900801. 10.1177/1947603519900801[Published online ahead of print]
159
ZhouX.JiangL.FanG.YangH.WuL.HuangY.et al (2019). Role of the ciRS-7/miR-7 axis in the regulation of proliferation, apoptosis and inflammation of chondrocytes induced by IL-1β.Int. Immunopharmacol.71233–240. 10.1016/j.intimp.2019.03.037
160
ZhouY.LiS.ChenP.YangB.YangJ.LiuR.et al (2019). MicroRNA-27b-3p inhibits apoptosis of chondrocyte in rheumatoid arthritis by targeting HIPK2.Artif. Cells Nanomed. Biotechnol.471766–1771. 10.1080/21691401.2019.1607362
161
ZhouZ. B.DuD.HuangG. X.ChenA.ZhuL. (2018). Circular RNA Atp9b, a competing endogenous RNA, regulates the progression of osteoarthritis by targeting miR-138-5p.Gene646203–209. 10.1016/j.gene.2017.12.064
162
ZhouZ. B.HuangG. X.FuQ.HanB.LuJ. J.ChenA. M.et al (2019). circRNA.33186 contributes to the pathogenesis of osteoarthritis by sponging miR-127-5p.Mol. Ther.27531–541. 10.1016/j.ymthe.2019.01.006
163
ZhuY. J.JiangD. M. (2019). LncRNA PART1 modulates chondrocyte proliferation, apoptosis, and extracellular matrix degradation in osteoarthritis via regulating miR-373-3p/SOX4 axis.Eur. Rev. Med. Pharmacol. Sci.238175–8185.
Summary
Keywords
degenerative musculoskeletal disorders, aging, age-related disease, non-coding RNAs, miRNA, circRNA, lncRNA
Citation
Zheng Y-L, Song G, Guo J-B, Su X, Chen Y-M, Yang Z, Chen P-J and Wang X-Q (2021) Interactions Among lncRNA/circRNA, miRNA, and mRNA in Musculoskeletal Degenerative Diseases. Front. Cell Dev. Biol. 9:753931. doi: 10.3389/fcell.2021.753931
Received
05 August 2021
Accepted
22 September 2021
Published
11 October 2021
Volume
9 - 2021
Edited by
Zhao-Qian Teng, Institute of Zoology, Chinese Academy of Sciences (CAS), China
Reviewed by
Lei Zhao, University of Wisconsin-Madison, United States; Jun Zou, Soochow University, China
Updates
Copyright
© 2021 Zheng, Song, Guo, Su, Chen, Yang, Chen and Wang.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Pei-Jie Chen, chenpeijie@sus.edu.cnXue-Qiang Wang, wangxueqiang@sus.edu.cn
†These authors have contributed equally to this work and share first authorship
This article was submitted to Epigenomics and Epigenetics, a section of the journal Frontiers in Cell and Developmental Biology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.